ARHGAP26 and Lewy body dementia: Thus, because of the correlating anti-ARHGAP26 autoantibodies, we suggest a diagnosis of atypical DLB according to two fulfilled core features (fluctuating cognition, Parkinsonism) and one positive indicative biomarker, namely confirmed pathological I123 CIT-SPECT.